InMed Pharmaceuticals Inc. (NASDAQ: INM) revealed its decision regarding the selection of an intravitreal (IVT) formulation for INM-089 as a drug candidate. This choice is part of the company’s ...

Inmed Pharmaceuticals Inc. has selected an intravitreal (IVT) formulation for INM-089 as a drug candidate to be utilized in the company’s ongoing development program targeting the treatment of dry age ...

InMed Pharmaceuticals ( ($INM) ) has provided an announcement. InMed Pharmaceuticals Inc. announced the selection of an intravitreal formulation ...

VANCOUVER - InMed Pharmaceuticals Inc. (NASDAQ: INM), a small-cap biotech company with a market capitalization of $2.21 million, has announced the selection of an intravitreal (IVT) formulation, ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a ...

InMed Pharmaceuticals (INM) announced the selection of an intravitreal, IVT, formulation for INM-089 as a drug candidate to be utilized in the ...

温哥华 - 市值221万美元的小型生物科技公司InMed Pharmaceuticals Inc. (NASDAQ: INM)宣布选定一种玻璃体内 (IVT)配方INM-089，用于进一步开发其针对干性年龄相关性黄斑变性 ...

INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...

DelveInsight's analysis indicates a promising outlook for the dry eye disease market from 2024 to 2034, with positive growth anticipated. This growth trajectory is attributed to the emergence ...

惠普森医药股票所在的制药行业中，整体跌幅为0.31%。其相关个股中，Cbdmd, Inc.、Painreform Ltd.、惠普森医药涨幅较大，Cbdmd, Inc.、Painreform Ltd.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为260.21%、26.07%、8.45%，振幅较大的相关个股有Cbdmd, Inc.、Painreform ...

北京时间2025年01月29日03时15分，Sonoma Pharmaceuticals, Inc.（SNOA.us）股票出现异动，股价大幅 拉升 5.07%。截至发稿，该股报2.77美元/股，成交量2.1868万股， 换手率 1.63%，振幅4.97%。